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Summary 
Lyophilised aqueous extract of Euphorbia hirta L. (Euphorbiaceae) has 
been evaluated for behavioral effects in mice. The extract did not induce any 
toxic effect when it was administered i.p. and orally. Sedative properties 
could be confirmed with high doses (100 mg of dried plantkg, and more), by 
a decrease of behavioral parameters measured in non-familiar environment 
tests (activitest and staircase test), whereas anticonflict effects appeared a t  
lower doses (12.5 and 25 mg of dried plantkg), by an enhancement of, behav- 
ioral parameters measured in the staircase test and in the light/dark choice 
situation test. These findings validate the traditional use of E. hirta as a 
sedative and reveal original anxiolytic properties. 
Introduction 
An ethnopharmacological study of Euphorbia hirta L. was undertaken to  
record its traditional therapeutic indications and to evaluate the pharmaco- 
logical properties according to  the traditional medicine (Lanhem, 1988). 
Euphorbia hirta L. (Euphorbiaceae), an herbaceous wild plant native to 
Australia, is now very common in all tropical countries and has been widely 
used in traditional medicine in Asia, the Middle East, Africa and the Carib- 
bean, where 183 vernacular names have been recorded (Lanhem, 1988). E. 
hirta has been recommended for various therapeutic indications in tradi- 
tional medicine, such as diseases of the digestive system (diarrhea, dysen- 
tery, constipation, ulcer, parasitosis. . .I, of the respiratory system (asthma, 
bronchitis, emphysema, hay fever. . .), of the urinary apparatus (stones, as a 
diuretic. . .I, of the genital apparatus (metrorrhagia, agalactosis, gonorrhea, 
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urethritis. . .), for various ocular ailments (conjunctivitis, corneal ulcer. . .I, 
affections of skin and mucous membranes (Guinea worm, scabies, tinea, 
thrush, aphtha. . J. Besides these principal indications, other different prop- 
erties have been mentioned, like hypotensive, tonic, antipyretic, antiinflam- 
matory, hypoglycemic and sedative activities (Watt and Breyer-Brandwijk, 
1962; Martin et al., 1964; Ridet and Chartol, 1964; Steinmetz, 1964; De Saqui- 
Sannes, 1971; Poulet, 1972; Zipcy, 1975; Ndir and Pousset, 1982; Dalil, 1984; 
Karimou, 1984; Weniger, 1985; Adjanohoun et al., 1986). 
Chemical composition of E. hirta has been widely studied and a review 
The present investigation was undertaken to  determine the possible seda- 
tive effects of E. hirta, effects otherwise suggested by Cabalion after field- 
works in Vanuatu (personal communication). An aqueous extract of E. hirta 
was prepared in accordance to the traditional know-how. 
In this aim, we have observed the behavior of mice confronted with sev- 
eral experimental situations. In the first experiment, we have examined the 
dose-effect relationships by recording the locomotor activity of mice con- 
fronted with an activitest. 
Experiment 2 was undertaken in order to confirm the sedative properties 
of the plant, by measuring exploratory behavior with a familiar environment 
test, the two compartment test, described in rats by Hughes (1965) and 
adapted for use in mice by Misslin and Ropartz (1981). 
Since numerous drugs, known for their sedative properties a t  high doses 
such as benzodiazepines, also present anticonflict effects when administered 
at  low doses, we therefore studied in experiment 3 possible anticonflict 
effects of E. hirta with non-familiar environment tests, the staircase test 
described in rats by Thibbot e t  al. (1976) and adapted to  mice by Misslin et 
al. (1975), and the two-chambered light/dark test concieved by Crawley and 
Goodwin (1980) and modified by Belzung et al. (1987). 
Material and methods > 
Plant extract 
extract was prepared in the following manner: powdered whole dried plant 
(60 g) was infused in boiling water (400 ml) and then macerated for 24 h a t  
44 OC. The macerate was filtered and lyophilised. The yield of extraction was 
14% & 1. 
The characterization of the aqueous extract was limited to the qualitative 
chemical identification and thin-layer chromatographies of different sub- 
stances as gallic and catechic tanins, flavonoid compounds, organic acids, 
amino acids, glucides, saponosides and reducing compounds, according to the 
literature (Lanhem, 1988). 
In this paper, all doses are expressed in terms of dried plant material (mgl 
kg of body weight). 
R 
P has been previously published (Lanhem et al., 1987). 
) 
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E. hirta was harvested in Vanuatu (New Hebrides) in 1984. An aqueous ;i 
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Animals 
Male Swiss mice (Laboratories Janvier, Le Genest, France) weighing 30- 
35 g (8-9 weeks of age) were used for behavioral tests and male and female 
Swiss mice for acute toxicity determination. 
All animals were conditioned in standard macrolon boxes (five mice per 
box). They were fed laboratory diet (croquettes Extralabo, Provins, France) 
ad libitum and allowed free access to drinking water. They were kept in 121 
12 h light/dark cycle with lights on at  midnight, in order to observe animals 
during their dark high activity period. 
Experiment 1 
Activitest: The apparatus consisted of a standard cage i24 x 11 x 10 cm) 
standing on two wires connected to four quartz crystals. The impulses from 
the crystal induced by any movement (including breathing) are amplified and 
transmitted to a counter. 
Each subject was placed in the experimental cage immediately before the 
start of the test. Then, the general activity of the animal was recorded min- 
ute per minute, during 5 min. 
Plant extract was administered i.p., 30 min before testing, a t  50, 100, 200, 
400 and 800 mgkg. The control animals received NaCl 0.9 O/o solution in the 
same experimental conditions. Each treated group was composed of 10 mice 
and control group of 50 mice. 
Experiment 2 
Two compartment test: The apparatus consisted of a polyvinylchloride 
box (30 x 20 x 20 cm), subdivided into six equal square exploratory units 
and covered with plexiglass. It could be divided in half by means of three 
temporary partitions. The apparatus was kept on a stand in the room which 
housed the mice. During observation, the experimenter stood next to the 
box, always at  the same place. The observations were made without prior 
knowledge of the animal's experimental conditions. 
Each subject was placed in one half of the apparatus with the temporary 
partitions in place, in order to be familiarized with it. The floor was covered 
with sawdust and the animal was given unlimited access to food and water. 
Approximately 24 h after being placed in the apparatus, the animal was 
exposed to  both familiar and novel environments by the removal of the tem- 
porary partitions without itself being taken out of the box ('free 
exploration'). The subject was then observed, in red light, for 10 min. The 
number of novel and/or familiar units entered by the subject was recorded 
every minute as locomotor activity (locomotor activities in the familiar com- 
partment, in the novel compartment and total locomotor activity). 
Plant extract was administered i.p., 30 min before testing, at 12.5, 25, 50, 
100 and 200 mg/kg. The control animals received NaCl 0.9% splution in the 
same experimental conditions. Each treated group was composed of 10 mice 
and control group of 20 mice. 
' 
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Experiment 3 
Staircase test: The apparatus consisted of a polyvinylchloride enclosure 
(47 x 10 x 25 cm) with a staircase of five steps. A light from a 100-w desk 
lamp above the staircase provides the only room illumination. 
The animal was placed singly on the floor of the box with its back to the 
staircase. The number of steps climbed and rearings were counted minute 
per minute, during 5 min. A step was considered to be climbed only if the 
mouse had all four paws on the step. The number of steps descended was 
not taken into account, in order to simplify the observations. After each test 
session, the box was cleaned to  eliminate any olfactory cue which might 
modify the next animal’s behavior. 
Plant extract was administered i.p., 30 min before testing at  doses of 6.25, 
12.5, 25, 50, 100 and 200 mglkg. Clorazepate dipotassium, a reference benzo- 
diazepine (TranxeneR, Laboratories Clin-Midy, Paris), was administered at  
’ 
doses of 1, 5, 10, 20 and 40 mglkg. The control animals received NaCl 0.9 Yo 
solution in the same experimental conditions. Each group was composed of 
10 mice. - 
Light/dark choice situation test: The apparatus consisted of two polyvi- 
nylchloride boxes (20 x 20 x 14 cm) covered with plexiglass. One of these 
was darkened with cardboard. A light from a 100-w desk lamp above the 
other box provided the only room illumination. An opaque plastic tunnel (5 
x 7 x 10 cm) separated the dark box from the light one. During observa- 
tion, the experimenter stood next to the apparatus, always at  the same 
place. 
The subjects were individually tested in 5-min sessions. Testing was per- 
formed between 1400 h and 1600 h. Mice were naive to the apparatus and 
had no previous drug treatment. All animals were placed in the illuminated 
box to initiate the test session. The amount of time spent in this box was 
recorded minute per’minute, during 5 min after the first entry of mice in the 
dark box. A mouse whose four paws were in the new box was considered as 
having changed boxes. 
Plant extract was administered i.p., 30 min before testing, a t  doses 12.5, 
experimental conditions. Each treated group was composed of 10 mice and 
control group of 20 mice. 
Acute toxicity 
Groups of 10 mice (5 male and 5 female) received the lyophilised aqueous 
extract a t  3 and 6 glkg, i.p. and p.o. Mortality and different physiological and 
behavioral effects (skin state, salivation, whimpering, trembling, locomotion, 
excrement. . .) were noted after 15 min, 1, 2, 4, 24 h and every day for 14 
days. The body weight of each mouse was measured every day. 
5 -  
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and 25 mglkg. The control animals received NaCl 0.9% solution in the same i,’ 
Statistics 
Activitest, two compartment test, light/dark choice situation test: Statisti- 
cal significances of differences between control and treated groups were 
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ascertained by a combined analysis of variance and an impaired two-tailed 
range t-test using the Newman-Keds method. 
Staircase test: After the confirmation of the variances homogeneity (Bar- 
tlett's test) and an analysis of -variance, each treated group was compared 
with the corresponding control group, by the Student's t-test. 
ED,, were evaluated according to the method described by Litchfield and 
Wilcoxon (1949). 
Results 
Experiment 1 
Activitest: The results represented in Fig. 1 show that E. hirta produced 
a significant and dose-dependent decrease of seneral activity from 100 mgl 
kg. ËD,, was estimated to 227 mgkg r 3. 
u 
general activity in 5 min. 
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Fig. 1. Influence of E. hirta on general activity of mice recorded in the activitest. 
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Fig. 2. Influence of E. hirta on locomotor activity of mice in the two compartment test. 
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Fig. 3. Influence of E. hirta on rearings and steps climbed by mice in the staircase test. 
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Experiment 2 
Two compartment test: As can be seen in Fig. 2, E. hirta significantly 
reduced the total locomotor activity from 12.5 mglkg, while activities in the 
familiar and in the novel compartments were significantly affected only from 
25 mglkg. ED,, was estimated to 46 mgkg -i- 1. 
Experiment 3 
Staircase test: The results represented in Fig. 3 demonstrate that E. hirta 
decreased significantly the number of steps climbed and the number of rear- 
ings effected by mice, from 100 mglkg. At  lower doses (12.5 and 25 mgkg), 
the effects were reversed, the plant extract significantly increasing the 
number of rearings; however, the number of steps climbed was significantly 
* P 0.05 *+ P ( 0.01 *** P ( 0.01 
Fig. 4. Influence of clorazepate dipotassium on rearings and steps climbed by mice in the stair- 
case test. 
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TABLE 1 
EFFECT OF E. HLRTA ON THE TIME SPE”l’ BY MICE IN THE ILLUMINATED BOX 
N: number of mice per group. 
Dose mgkg Time spent in the N 
Control 30.4 2 1.9 20 
12.5 34.8 2 2.4 10 
25 40.3 2 2.7* 10 ”I 
*P < 0.05. 
illuminated boxls 
í 
affected only at  12.5 mglkg. Sedative ED, were estimated to 75 mglkg -r- 1 
for the rearings and to 99 mgkg +. 1 for the steps climbed. 
The reference compound, clorazepate dipotassium, significantly increased 
the number of rearings and of steps climbed at 1 and 5 mglkg, and signifi- 
cantly reduced the former parameter from 20 mglkg (Fig. 4). Sedative ED,, 
were estimated to 16 mglkg + 1  for the rearings and to 23 mglkg +. 1 for 
the steps climbed. 
Light/dark choice situation test: Table 1 shows that E. hirta significantly 
increased the time spent by the mice in the illuminated box, a t  12.5 and 25 
mglkg. 
Acute toxicity 
The aqueous extract of E. hirta administrated i.p. and p.o. did not induce 
the mortality up to  the dose of 6 g/kg. The treated animals did not present 
any toxic manifestation. The evolution of body weight was normal in all 
treated animals. 
Discussion 
i,” 
The present results indicate that the aqueous extract of E. hirta L. 
appears t o  have sedative properties, since it significantly reduced the gen- 
eral activity of mice in a forcing-test (activitest), as well as the number of 
steps climbed and rearings effected by mice confronted to another aversive 
situation (staircase test), the lowest active dose being 100 mg of dried plant/ 
kg. Moreover, this sedative activity appears a t  lower doses, when mice are 
confronted with a free-choice exploratory situation (two compartment test) 
on this particular situation, the locomotor activity was significantly reduced 
from 12.5 mgkg. 
Furthermore, it is well known that many sedative drugs such as 
benzodiazepines, phenobarbital, valproate or ethanol, when administered at  
low doses, have also been found to possess anticonflict properties (Misslin et 
al., 1975; Treit, 1985). In the present study, we used the staircase test and 
the lightldark choice situation, in order to observe a possible anxiolytic 
action of E. hirta. 
h 
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It has been demonstrated that, in experimental situations in which ani- 
mals are forced into a novel environment, they actually- attempt to  escape 
(Misslin et al., 1982; Misslin and Cigrang, 1986). Minor tranquilizers facilitate 
this behavior, presumably by suppressing behavioral inhibition induced by 
the aversive properties of forced situations. 
In the staircase test, these anticonflict properties found expression in the 
increase of the number of steps climbed and rearings effected by the mouse, 
such effects obtained in this study with clorazepate dipotassium from the 
lowest doses of 1 and 5 mglkg. 
In this test, E. hirta produced a significant increase in the number of rear- 
ings, a t  the low doses of 12.5 and 25 mg of dried plantkg, but its action on 
the number of steps climbed is clearly slight, and significant only at  12.5 mgl 
kg. In the lightldark choice situation, anticonflict activity of E. hirta found 
expression in the increase of the time spent by mice in the illuminated box, 
when it was used a t  the doses of 12.5 and 25 mg of dried plantkg. 
Thus, the sedative effects of a traditional extract of E. hirta (aqueous 
extract) have been largely demonstrated and so validate one of the various 
therapeutic indications of Chis species. These data also reveal a new pharma- 
cological effect for E. hirta, its anxiolytic properties. 
It will be necessary to clarify the activity profile of this species by 
researching other benzodiazepine-like properties, as well as other possible 
psychotropic effects, such as hypnotic, neuroleptic and antidepressant 
effects. These investigations will be the subject of following publications. 
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